baber/WOPTO huggingface dataset:
Patent NZ-584339-A (NZ)
Title: A portable human body pulsating apparatus and a thoracic therapy garment
Inventor: HELGESON LONNIE J
IPC: A61H31/00
Filed: 2008-09-29
Abstract: Disclosed is a portable human body pulsating apparatus (10) and a thoracic therapy garment (30) locatable around the thorax of a person to apply repetitive compression forces to the thorax of the person comprising: an air pulse generator (11) for creating air pressure and air pressure pulses, said generator including a housing (12), a pedestal (29) having an upper end, a frame assembly mounted on the upper end of the pedestal, fasteners securing the housing to the frame assembly, surface support members (32-39) connected to the pedestal to facilitate movement of the body pulsating apparatus on a surface, said thoracic therapy garment including a body having a plurality of chambers for accommodating air, said body including an end section having opposite sides, releasable fasteners attached to the opposite sides of the end section of the body to selectively retain the thoracic therapy garment clockwise or counterclockwise around the thorax of a person, an air inlet connector mounted on the body having a passage open to the chambers, and a hose (61) connecting the generator to the air inlet connector whereby air and air pressure pulses flow from the generator through the hose and air inlet connector into said chambers thereby applying repetitive pressure pulses to the thorax of a person having the thoracic therapy garment located around the thorax of the person. The portable human body pulsating apparatus (10) has an air pulse generator (11) mounted on a pedestal (29) having wheels (38) to facilitate movement of the apparatus (10) on a surface. The pedestal (29) has an upright piston and cylinder assembly (31) operable to adjust the elevation of the air pulse generator (11). A reversible thoracic therapy garment (30) is connected with a hose (61) to an air pulse generator (11) which can be selectively located adjacent opposite sides of a person receiving therapy. This portable medical device operable with a thoracic therapy garment is used for applying repetitive compression forces to the body of a person to aid blood circulation, loosen and eliminate mucus from the lungs and trachea in the respiratory tract and relieve muscular and nerve tensions.
Patent NZ-586732-A (NZ)
Title: Method for blending ice and flavour to make frozen slurry beverage in disposable cup with wall requiring no support during blending
Inventor: ALMBLAD ROBERT
IPC: F25C5/12
Filed: 2009-01-15
Abstract: 586732 A method and apparatus for preparing a single serving of a frozen slurry beverage (10) in a disposable drink container or cup (12) by preparing a supply of fine frozen particles of water in the form of ice flakes and/or ice nuggets of compressed ice flakes, depositing a predetermined quantity or amount of the fine frozen particles of partially frozen water (20) into a disposable single serving drinking cup or container, dispensing or adding a predetermined quantity or amount of flavored liquid beverage mix into the disposable single serving drinking cup or container and blending the fine frozen particles of partially frozen water and the flavored liquid beverage mix into a substantially uniform frozen slurry beverage of a predetermined consistency. The single serving disposable drink container has a side wall and bottom surface, the side wall requiring no external support during blending.
Patent NZ-592651-A (NZ)
Title: Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin
Inventor: PIERGALLINI REMIGIO
IPC: A23L11/00
Filed: 2009-11-06
Abstract: ABSTRACT - 592651 Disclosed herein is a method for the treatment of a skin condition or for skin rejuvenation which comprises the steps of: (a) topically applying on a non-human animal's skin a composition comprising at least one oxidant, wherein the at least one oxidant is chosen from hydrogen peroxide, carbamide peroxide and benzoyl peroxide, at least one photoactivator capable of activating the oxidant, wherein the at least one photoactivator is eosin, and at least one healing factor chosen from hyaluronic acid, glucosamine and allantoin; and (b) exposing said skin of step (a) to actinic light for a time sufficient for said photoactivator to cause activation of said oxidant.
Patent NZ-593694-A (NZ)
Title: Topically active steroids for use in radiation and chemotherapeutics injury
Inventor: BREY ROBERT N
IPC: A01N37/00
Filed: 2009-12-08
Abstract: 593694 Disclosed is the use of beclomethasone dipropionate, beclomethasone-17-monopropionate or 21-beclomethasone monopropionate in the manufacture of a medicament for treating the severity of cellular and tissue damage due to epithelial cytotoxicity in a subject who has been exposed to a damaging amount of radiation or chemotherapeutics agents, wherein the medicament is for use in a method comprising administering beclomethasone dipropionate to the gastrointestinal tract of the patient. The medicament can be used for ameliorating or treating damage to the gastrointestinal tract of a patient wherein the damage is a result of the patient's exposure to chemotherapy and/or radiation. The medicament can comprise other agents. The medicament can be topical such as an enema or in an oral dosage that releases the compound in the gut lumen.
Patent NZ-595093-A (NZ)
Title: Performance monitoring system
Inventor: RAGUNATHAN REVATHI
IPC: G06Q10/06
Filed: 2011-09-08
Abstract: A computer implemented method and a performance monitoring system for monitoring performance of an organization are disclosed. The performance monitoring system (102) comprises a processor (202); and a memory (206) coupled to the processor. The memory comprises a performance monitoring module, a parameter analysis module and a user interaction module. The performance monitoring module (110) is configured to extract performance data associated with a plurality of performance parameters indicative of performance of the organization at a hierarchy level. The parameter analysis module (216) is configured to determine values for each of the plurality of performance parameters. The values are based at least in part on preset parameter rules and the performance data. The parameter analysis module is configured then to link one or more of the plurality of performance parameters associated with the hierarchy level to other hierarchy levels based upon the preset parameters rules. The user interaction module (218) is configured to provide, to a user, one or more performance parameters from among the plurality of performance parameters based on a subscription to the one or more performance parameters.
Patent NZ-600158-A (NZ)
Title: Installation method of radiating elements disposed on different planes and antenna using same
Inventor: JUNG IN-HA
IPC: H01Q5/00
Filed: 2010-11-17
Abstract: Disclosed is an antenna having radiator elements (21, 22) arranged on different planes. The antenna is comprised of a first-position radiator element (21) placed on one plane, a second-position radiator element (22) placed on another plane, and power supply cables (211, 221) connected to the first-position radiator element (21) and the second-position radiator element (22). The lengths of the power supply cables (211, 221) are selected to compensate for a phase difference between signals radiated into the air from the first-position radiator element (21) and the second-position radiator element (22). This phase difference is a result of the position difference (ΔLa) between the two radiating elements (21, 22). This is compensated for by a difference in lengths (ΔLc) between the two power supply cables (211, 221).
Patent NZ-603985-A (NZ)
Title: Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
Inventor: EVEN LUC
IPC: C07D413/12
Filed: 2011-06-06
Abstract: Disclosed herein are hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application. An example of which is 2,2,2-trifluoro-1-(trifluoromethyl)ethyl 4-(5-chloro-2-oxo-2,3-dihydrobenzimidazol-1-yl)piperidine-1-carboxylate. The compounds have an inhibitory effect on enzyme MGL (monoacyl glycerol lipase) and are therefore intended for the treatment of conditions such as pain, metabolic disorders, allergic and inflammatory disorders.
Patent NZ-610180-A (NZ)
Title: Direct smelting process
Inventor: DRY RODNEY JAMES
IPC: F27D3/18
Filed: 2012-02-09
Abstract: 610180 A molten bath-based process for direct smelting metalliferous material and producing molten metal in a direct smelting vessel (11) that contains a molten bath that has a metal layer (22) that is at least 900 mm deep. The process includes selecting operating parameters of the process so that feed material (solid material and carrier gas) is injected from above the metal layer into the metal layer (22) via at least one solids injection lance (27) with sufficient momentum to penetrate to a depth of at least 100 mm below a nominal quiescent surface of the metal layer (22) to cause upward movement of molten material and gas (69) from the metal layer (22).
Patent NZ-610359-A (NZ)
Title: Connection enclosure assemblies, connector systems and methods for forming an enclosed connection between conductors
Inventor: SHRUM MAIGAN G
IPC: H01R4/70
Filed: 2009-07-23
Abstract: Disclosed is an enclosure assembly for use with an electrical connector to provide termination or joining of electrical conductors or wires with wedge shaped terminal blocks or connector for use in electrical power transmission lines. The enclosure assembly comprises an enclosure including at least one cover member defining a cover member cavity to receive the connector; and a flowable gel sealant disposed in the cover member cavity to provide a seal about the connector; wherein a pre-defined void is formed in the sealant to receive the connector prior to insertion of the connector into the enclosure assembly. the enclosure includes first and second cover members defining first and second cover member cavities respectively. A first flowable sealant disposed in the first cover member cavity and a second flowable sealant disposed in the second cover member cavity. The first and second cover members are relatively movable between an open position to receive the connector and a closed position wherein the first and second cover members define an enclosure cavity to contain the connector such that the connector is encapsulated in the first and second sealants. The enclosure is configured such that the connector will displace the first and second sealants when the first and second cover members are moved from the open position to the closed position about the connector. The first and second sealants are first and second gels adapted to be elongated and elastically deformed in the closed position when the connector is disposed in the enclosure cavity.
Patent NZ-620005-A (NZ)
Title: Pharmaceutical composition comprising ebastine and fluticasone
Inventor: MALHOTRA GEENA
IPC: A61P27/14
Filed: 2012-08-02
Abstract: Provided are pharmaceutical compositions comprising the combination of the antihistamine ebastine and the corticosteroid fluticasone. The compositions are for ophthalmic or nasal use. The compositions may be useful in the treatment of allergic rhinitis, uritcaria and nasal polyps.
Patent NZ-621163-A (NZ)
Title: Intraocular implant cell migration inhibition system
Inventor: CUEVAS KEVIN H
IPC: A61F2/16
Filed: 2012-08-01
Abstract: Disclosed is an intraocular implant. The implant includes a biocompatible flexible membrane having flat front and back surfaces disposed a uniform thickness apart and implanted between an intraocular lens and a surface of a posterior capsule of an eye. The biocompatible flexible membrane has an outer boundary which defines a circular area having a diameter of between about 9 millimeters and about 15 millimeters, the outer boundary configured to be located proximate an outer circumference of the posterior capsule. The implant has patterned surface elements coupled to at least one of the front surface and the back surface of the biocompatible flexible membrane. The patterned surface elements have dimensional relations adapted to inhibit migration of cells between the intraocular lens and the surface of the posterior capsule of the eye. The implant further includes an aperture element which defines a passage opening capable of providing fluid communication to the intraocular implant between the front surface and the back surface of the biocompatible flexible membrane, the passage opening configured to intraocularly align in a visual axis of the eye with the outer boundary configured to be located proximate the outer circumference of the posterior capsule, thereby providing a line of sight which passes through the passage opening.
Patent NZ-625362-A (NZ)
Title: A connector, and a teatcup
Inventor: LIDMAR ANNELI
IPC: A01J5/08
Filed: 2012-12-20
Abstract: The invention refers to a connector and a teatcup comprising a connector (2) and a cartridge. The cartridge comprises a sleeve, having a first end and a second end, and a teatcup liner mounted in the sleeve and having a inner space for receiving a teat. The connector is configured to connect a milk conduit to the cartridge. The connector comprises a casing (24), which defines a longitudinal centre axis (x) and encloses a connection space (27). The casing has en inner surface facing the connection space. The casing comprises an inlet opening (28) for the cartridge to the connection space, and an outlet opening (29) for the milk conduit. Locking means is provided on the inner surface of the casing and configured to permit locking of the cartridge in the connector. The teatcup also includes a protective outer shell for shielding the cartridge from damage.
Patent NZ-628699-A (NZ)
Title: Process for improved opioid synthesis
Inventor: MCCARTHY KEITH
IPC: C07D489/08
Filed: 2013-07-15
Abstract: Compounds and compositions for use as starting materials or intermediate materials in the preparation of opioids including, e.g., oxymorphone base and/or an oxymorphone salt; processes for preparing these compounds and compositions; uses of these compounds and compositions in the preparation of APIs and pharmaceutical dosage forms; and uses of said APIs and pharmaceutical dosage forms in the treatment of medical conditions.
Patent NZ-703442-A (NZ)
Title: Matched pattern signal decoding
Inventor: MAHNAD FARAMARZ
IPC: G11B20/14
Filed: 2013-09-24
Abstract: The invention seeks to provide an optical tape decoding system with reliable and improved decoder functionality because under excessive noise, the reliability of decoder functionality is often compromised. Disclosed is an optical tape decoding system comprising a decoder that is configured to apply a matched pattern signal (72) representing an address index to a track address signal (74) including a multi-cycle wobble block representing the address index such that a signal is output having a peak corresponding to the multi- cycle wobble block. The decoder also identifies the address index based on an amplitude of the peak. The decoder is further configured to, in response to identifying the address index, identify a predetermined pattern of bits trailing the address index to confirm a location of the address index. Initially detecting an index waveform, and thereafter detecting a second pattern at a certain amplitude and timing from the index waveform verifies that the index waveform was accurately detected.
Patent NZ-703854-A (NZ)
Title: Improved frame for climbing screen
Inventor: ROSATI WASYL
IPC: E04G21/32
Filed: 2013-06-26
Abstract: A safety screen assembly (1) comprising a base (3) for fixing with respect to a slab (20) of a building, a bracket for a raising means depending from the base (3), a frame means (2) depending from the bracket, a safety screen (10) depending from the frame means (2), where the frame means (2) and the safety screen (10) overhang said bracket so that the safety screen (10) is spaced apart from both the bracket and an edge of the slab (20), and wherein the frame means (2) is adapted to support a person in a position between the edge of the slab (20) and the safety screen (10), and wherein in a primary mode of use, the or each bracket is operatively associated with the frame to permit upward movement of the frame means (2) and the safety screen (10) with respect to the base (3), so that the raising means can raise these, but not downward movement.
Patent NZ-709660-A (NZ)
Title: Container with a medal
Inventor: SMITH ROGER
IPC: B65D55/06
Filed: 2014-03-06
Abstract: For some applications, containers require a marker for tracking, anti-counterfeiting, tamper-indicating, and or use-indicating purposes. One option is to include a medal on the container; however, difficulties can be encountered in mounting the medal to the container. A package including a closure coupled to a container (10, 410, 1010) and a method of making the package are disclosed. The container includes a body wall and a medal (12, 412, 1012) retained to the wall by container material (36, 1036) of integral one-piece construction with the body wall and extending over at least a portion of the medal. The method includes the steps of forming the body wall of the container to include a medal retainer; and retaining a medal to the container by forming a portion of the medal retainer of the container body wall over a corresponding portion of the medal, wherein the step of forming the body wall of the container includes forming a radially outwardly extending peg in the body wall of the container, and the retaining step includes placing the medal over the peg and against the container body wall and swaging the peg to form a head on the peg to trap the medal between the head and the container body wall so that the medal is non-removably retained to the container. The medal and one or more portions of the container adjacent the medal may have a shared unique appearance. The medal exhibits an initial state of a visual characteristic in an as-packaged state, and the closure is coupled to a neck finish of the container, and the medal is coupled to a rest of the package by a flaccid loop coupled to the medal and having a portion captured between the closure and the container, wherein removal of the closure renders accessible and removable the flaccid loop. The medal retained to the container provides an attractive marker for tracking, anti-counterfeiting, tamper-indicating, and/or use-indicating purposes.
Patent NZ-715027-A (NZ)
Title: Compositions and methods for joint health
Inventor: BROWNELL LIDIA
IPC: A61K36/48
Filed: 2014-06-16
Abstract: The present invention relates to the use a composition comprising a mixture of a Morus alba extract from a plant material and a Curcuma longa extract from a plant material, wherein the Morus extract has an increase in an amount of one or more prenylated flavonoids as compared to the amount of the one or more prenylated flavonoids in the plant material and the Curcuma longa extract has an increase in an amount of one or more curcuminoids as compared to the amount or the activity of the one or more curcuminoids in the plant material for the manufacture of a medicament for modulating joint inflammation, joint pain, joint stiffness, cartilage degradation, or improving mobility, range of motion, flexibility and/or joint physical function.
Patent NZ-722456-A (NZ)
Title: Platform stabilization system
Inventor: LEWIS MICHAEL D
IPC: G01C19/72
Filed: 2014-12-23
Abstract: A platform stabilization system comprises a support frame, a platform and a plurality of isolators each extending directly between the support frame and the platform. Each isolator permits linear movement of the platform relative to the support frame with three degrees of freedom and permits rotational movement of the platform relative to the support frame with three degrees of freedom. The isolators cooperate to form an isolation array supporting the platform directly within, and spacing the platform from, the support frame. The isolation array permits limited linear movement of the platform within the support frame with three degrees of freedom and permits limited rotational movement of the platform relative to the support frame with three degrees of freedom. The isolation array is substantially more resistant to linear movement of the platform than to rotational movement of the platform and does not rotationally constrain the platform.
Patent NZ-725262-A (NZ)
Title: Cyclopropanamine compound and use thereof
Inventor: TOYOFUKU MASASHI
IPC: C07D417/14
Filed: 2015-04-09
Abstract: The present invention provides a compound having a lysine-specific demethylase-1 inhibitory action, and useful as a medicament such as a prophylactic or therapeutic agent for schizophrenia, developmental disorders, particularly diseases having intellectual disability (e.g., autistic spectrum disorders, Rett syndrome, Down’s syndrome, Kabuki syndrome, fragile X syndrome, Kleefstra syndrome, neurofibromatosis type 1, Noonan syndrome, tuberous sclerosis), neurodegenerative diseases (e.g., Alzheimer’s disease, Parkinson’s disease, spinocerebellar degeneration (e.g., dentatorubural pallidoluysian atrophy) and Huntington’s disease), epilepsy (e.g., Dravet syndrome) or drug dependence, and the like. A compound represented by the formula wherein each symbol is as defined in the present specification, or a salt thereof.
Patent NZ-727750-A (NZ)
Title: Means and methods for determining t cell recognition
Inventor: SPITS HERGEN
IPC: G01N33/50
Filed: 2015-06-05
Abstract: The invention provides improved screening methods for testing T cell recognition of T cell epitopes. Specifically, the invention provides a method for determining whether a sample from an individual contains T cells that recognize a tumor-specific T cell epitope or a T cell epitope from an autoantigen, or from a modified self-antigen, or from a pathogen, comprising: - inducing, enhancing and/or maintaining expression of Bcl-6 in at least one B cell; - inducing, enhancing and/or maintaining expression of an anti-apoptotic nucleic acid in said at least one B cell; - allowing expansion of said at least one B cell into a B cell culture; - incubating B cells of said B cell culture with at least one compound comprising said T cell epitope; - incubating the resulting B cells with T cells; and - determining whether at least one T cell recognizes said T cell epitope.
Patent NZ-730942-A (NZ)
Title: Integrated system and method for removing acid gas from a gas stream
Inventor: DENTON DAVID
IPC: B01D53/48
Filed: 2015-10-20
Abstract: Acid gas compounds are removed from a process gas such as, for example, syngas or natural gas, by flowing a feed gas into a desulfurization unit to remove a substantial fraction of sulfur compounds from the feed gas and flowing the resulting desulfurized gas into a CO2 removal unit to remove a substantial fraction of CO2 from the desulfurized gas.
Patent NZ-731966-A (NZ)
Title: Novel imaging composition and uses thereof
Inventor: DONNELLY PAUL STEPHEN
IPC: C07K17/06
Filed: 2015-10-16
Abstract: The invention discussed in this application relates to hydroxamic acid-based compounds that are useful as imaging agents when bound to an appropriate metal centre, particularly for the imaging of tumours. The invention discusses a conjugate of: - a compound of formula (I): or a pharmaceutically acceptable salt thereof, and - a target molecule, wherein L is a leaving group selected from azide, halogen, cyanate and OR, wherein R is selected from C1 to C10 alkyl, C1 to C10 heteroalkyl, C2 to C10 alkene, C2 to C10 alkyne, and aryl, each of which is optionally substituted. The invention also discusses a radionuclide complex of a compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein L is a leaving group selected from azide, halogen cyanate and OR, wherein R is selected from C1 to C10 alkyl, C1 to C10 heteroalkyl, C2 to C10 alkene, C2 to C10 alkyne, and aryl, each of which is optionally substituted.